Home › Compare › KCOPX vs JNJ

KCOPX vs JNJ: Dividend Comparison 2026

KCOPX yields 8.01% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KCOPX wins by $14.0K in total portfolio value
10 years
KCOPX
KCOPX
● Live price
8.01%
Share price
$23.14
Annual div
$1.85
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.0K
Annual income
$1,329.75
Full KCOPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — KCOPX vs JNJ

📍 KCOPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKCOPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KCOPX + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
KCOPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KCOPX
Annual income on $10K today (after 15% tax)
$680.85/yr
After 10yr DRIP, annual income (after tax)
$1,130.29/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, KCOPX beats the other by $426.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KCOPX + JNJ for your $10,000?

KCOPX: 50%JNJ: 50%
100% JNJ50/50100% KCOPX
Portfolio after 10yr
$27.0K
Annual income
$1,078.77/yr
Blended yield
3.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KCOPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KCOPX buys
0
JNJ buys
0
No recent congressional trades found for KCOPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKCOPXJNJ
Forward yield8.01% ✓3.36%
Annual dividend / share$1.85$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$34.0K ✓$20.0K
Annual income after 10y$1,329.75 ✓$827.78
Total dividends collected$10.7K ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KCOPX vs JNJ ($10,000, DRIP)

YearKCOPX PortfolioKCOPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,501$801.00$10,676$355.77+$825.00 → KCOPX
2$13,167$860.96$11,407$389.39+$1.8K → KCOPX
3$15,010$921.20$12,198$426.53+$2.8K → KCOPX
4$17,042$981.43$13,056$467.62+$4.0K → KCOPX
5$19,276$1,041.40$13,987$513.12+$5.3K → KCOPX
6$21,727$1,100.88$14,998$563.56+$6.7K → KCOPX
7$24,407$1,159.63$16,098$619.52+$8.3K → KCOPX
8$27,333$1,217.48$17,295$681.69+$10.0K → KCOPX
9$30,521$1,274.24$18,599$750.82+$11.9K → KCOPX
10$33,987$1,329.75$20,022$827.78+$14.0K → KCOPX

KCOPX vs JNJ: Complete Analysis 2026

KCOPX — Stock

KKR Credit Opportunities Portfolio is a closed-end management investment company, which engages on investments in a portfolio of securities of specialty finance and other financial companies. The company was founded on September 5, 2019 and is headquartered in San Francisco, CA.

Full KCOPX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this KCOPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KCOPX vs SCHDKCOPX vs JEPIKCOPX vs OKCOPX vs KOKCOPX vs MAINKCOPX vs ABBVKCOPX vs MRKKCOPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.